← All articles
Golden oil droplets suspended in clear water, one large droplet breaking into smaller ones, on a dark green and amber background

A fatty acid lowered senescent-cell markers in old mice in weeks

For anyone following the search for drugs that clear aged cells: what a short course did in old mice, how a common gene variant in people fits in, and why it is no reason yet to change diet or supplements.

Senescent cells, the damaged cells that stop dividing and build up with age, turn out to run short of one particular fatty acid. When researchers gave that fatty acid back to cells in the lab, the senescent ones died. When they gave it by mouth to old mice, aged 22 to 24 months, markers of senescent cells fell in fat and liver within about three weeks. The study, led by Christopher Wiley at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, appeared online in Cell on 2 November.

What the cells were missing

The fatty acid is dihomo-gamma-linolenic acid, or DGLA, an omega-6 that sits midway on the chain the body uses to make arachidonic acid. The enzyme that turns DGLA into arachidonic acid is called delta-5 desaturase and is encoded by the FADS1 gene.

Senescent cells took up more of several polyunsaturated fatty acids than normal cells, yet their membranes held less DGLA. They also carried other features that make a cell prone to ferroptosis, an iron-dependent cell death driven by oxidised fats in the membrane: more free iron, more lipoxygenase enzymes and low-level membrane oxidation. Adding DGLA tipped them into ferroptosis. Blocking delta-5 desaturase did the same. According to the University of Eastern Finland, one of the participating institutions, healthy cells were largely spared.

What happened in old mice

Old mice received DGLA by mouth for five consecutive days and were examined two weeks later. In reporter mice that glow where the senescence gene p16 is active, the glow dropped. Staining for senescent cells was lower in fat and liver, and inflammatory signals typical of senescent cells fell in fat in both sexes.

Other changes were mostly seen in males. Old male mice had less liver scarring, lower levels of the liver enzyme AST, higher albumin, fewer clusters of inflammatory cells in the liver and lower blood urea, which the authors read as better kidney function. Female mice had almost no liver scarring to begin with, and their liver blood tests did not change. Not everything moved the right way: fat in the liver increased, which the authors suggest may be the extra DGLA being stored.

Lifespan was not measured, and neither were strength, endurance or frailty.

The team also used tissue from the Kuopio Obesity Surgery Study in Finland: fat samples from 185 people with obesity, 131 women and 54 men according to the 2024 preprint of the same work. In the women, and in all 185 people combined, a FADS1 variant that converts DGLA more slowly went with lower p21, a senescence marker, in fat. In the 54 men the same direction was not statistically significant. Another marker, p16, did not differ by genotype. This is an association in one group of people with obesity from a surgery study, not a test of DGLA as a treatment.

Why this is still far from people

The intervention evidence comes from cells and mice, after a short course and a two-week follow-up. The authors themselves write that clearing senescent cells by ferroptosis in living animals remains somewhat speculative, because DGLA has other effects in the body, including feeding anti-inflammatory signalling molecules. This study did not test safety or efficacy in people, and it gives no basis for changing diet or taking fatty-acid supplements. Anyone thinking about it should discuss it with their doctor.

Christopher Wiley is an inventor on patent applications on eliminating senescent cells with DGLA, delta-5 desaturase inhibitors and other ferroptosis inducers. The work was funded by the US Department of Agriculture, the US National Institute on Aging and private ageing-research foundations.

The search for drugs that remove senescent cells has so far produced clear results only in animals; a mineral salt that extended life in old male mice, reported earlier this month, is another example. What sets this study apart is a link to a natural genetic difference in people, which gives the idea a target worth testing.

Sources

  • Kuehnemann C, Jezak ST, Mogck BA, et al. Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis. Cell, online 2 November 2026. doi:10.1016/j.cell.2026.09.036, PubMed 42971201

  • Preprint of the same work: Kuehnemann C, et al. Fatty acid desaturation guides cellular decisions between ferroptosis and cellular senescence. bioRxiv, 3 October 2024, not peer reviewed. doi:10.1101/2024.10.03.616257

  • University of Eastern Finland. Fatty acid metabolism may help eliminate damaged and senescent cells. 3 November 2026. uef.fi

This article is for information only and does not replace a consultation with a doctor.

Articles in this section are educational and are not medical advice, a diagnosis, or a prescription. Consult a qualified professional before acting on anything you read here.

Read next